We herein report a case of T-PLL with a novel SEPT9-ABL1 fusion gene which induced strong resistance to tyrosine kinase inhibitors such as imatinib and dasatinib.     ///    Identification of a novel SEPT9-ABL1 fusion gene in a patient with T-cell prolymphocytic leukemia.. 